1. Home
  2. CTBI vs PHAT Comparison

CTBI vs PHAT Comparison

Compare CTBI & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community Trust Bancorp Inc.

CTBI

Community Trust Bancorp Inc.

HOLD

Current Price

$58.25

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$10.37

Market Cap

894.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTBI
PHAT
Founded
1903
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
894.0M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
CTBI
PHAT
Price
$58.25
$10.37
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$59.00
$19.50
AVG Volume (30 Days)
52.9K
967.8K
Earning Date
04-22-2026
05-28-2026
Dividend Yield
3.59%
N/A
EPS Growth
17.79
42.72
EPS
5.43
N/A
Revenue
N/A
$175,110,000.00
Revenue This Year
$14.02
$91.62
Revenue Next Year
$4.30
$59.82
P/E Ratio
$10.89
N/A
Revenue Growth
N/A
216.93
52 Week Low
$44.60
$2.21
52 Week High
$65.79
$18.31

Technical Indicators

Market Signals
Indicator
CTBI
PHAT
Relative Strength Index (RSI) 37.35 35.03
Support Level $53.77 $7.82
Resistance Level $59.48 $12.77
Average True Range (ATR) 1.91 0.80
MACD -0.42 -0.03
Stochastic Oscillator 21.15 7.28

Price Performance

Historical Comparison
CTBI
PHAT

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and south-central Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services. The company operates in one reportable segment: community banking services.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: